On October 22, Rocket Lab USA, Inc. fell 5.31% in Regular Trading, trading at $50.78, with turnover of $279 million.
The move aligns with the latest market narrative that sentiment remains pressured by the company’s previously disclosed delay of the Neutron inaugural launch to 2027, which has led investors to keep reassessing program timing and delivery expectations.
Recent disclosures said the delay stemmed from an issue in the forward dome manufacturing process. The stock had rebounded a day earlier after the company set its third-quarter earnings date for November 9, with market consensus for EPS at negative $0.05, but that recovery was reversed as the delay overhang persisted. Earlier reports also noted ARK had added shares following the sharp selloff, though near-term sentiment repair appeared limited.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments